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It was shown that calmddulin (CM) activates the adenylate cyclase (AC) of rabbit heart light sarcolemma 
in the presence of micromolar free CaZ+ concentrations and this effect is blocked by trifluoroperazine and 
troponin I. GTP (in the presence of isoproterenol) and Gpp(NH)p are able to increase the CM-dependent 
activity of enzyme. It was concluded that there is no special CM-dependent ‘form’ of AC in the heart and 
the common catalytic omponent ofAC can be regulated both by CM and guanine nucleotide-binding re u- 
latory component (N-protein). In the presence ofCaz+ and guanine nucleotide heart AC exists as a complex: 
CM-catalytic omponent-N-protein. 
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1. INTRODUCTION 
Ca2+ inhibits the activity of adenylate cyclase 
(AC) from a wide variety of tissues (review [l]). 
However, the mammalian cerebral cortex and 
some other tissues contain an AC that is activated 
by micromolar concentrations of Ca2+. It was 
shown that this activation is mediated by 
calmodulin (CM) [2-51. There is still a view that 
cardiac AC is insensitive to this stimulatory 
Ca2+-dependent action of CM, and that Ca2+ ex- 
erts only an inhibitory effect on cyclic AMP 
(CAMP) synthesis in the heart [6,7]. This paper 
presents evidence for the heart AC ability to be ac- 
tivated by Ca2+ through CM. 
A pivotal role in AC regulation is played by the 
guanine nucleotide-binding regulatory protein (N- 
protein), which is necessary for the expression of 
the AC catalytic component enzymatic activity in 
the presence of Mg2+. Hormones in the presence of 
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Abbreviation: GPPW-QP, 
imido)triphosphate 
guanosine 5 ’ -ca,y- 
GTP, synthetic poorly hydrolyzable analogues of 
GTP such as Gpp(NH)p, NaF and cholera toxin 
increase the AC activity by raising the concentra- 
tion of this functionally active catalytic 
component-N-protein complex (review [S]). Some 
researchers believe that CM activates the catalytic 
AC component without participation of N-protein 
[9, lo]. There are still other assumptions uggesting 
that CM and N-protein regulate different forms of 
AC [4,5]. 
It has been established here that guanine 
nucleotides, GTP (in the presence of isoproterenol) 
and Gpp(NH)p potentiate the effect of CM on 
heart AC. Our data give no reason to believe that 
a special CM-dependent form of AC exists in the 
heart. Apparently, CM activates the catalytic AC 
component associated with N-protein. This CM- 
dependent activation can be achieved through an 
increase in the AC catalytic turnover. 
2. MATERIALS AND METHODS 
Plasma membranes (light sarcolemma fraction) 
were isolated from the hearts of adult male rabbits 
according to recommendations in [ll]. After 
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decapitation, the animals’ hearts were rapidly 
removed, rinsed with chilled isotonic NaCl (0.9% 
NaCl), stripped of fat, and then the auricles were 
removed. All subsequent operations were perform- 
ed at 4°C. The ventricles were weighed, minced 
with scissors and placed in 5 vols (w/v) buffer A 
containing 10 mM imidazole (pH 7.5) at 4”C, 
1 mM EDTA, 1 mM MgClz and 250 mM sucrose. 
The tissue was homogenized with a Polytron 
homogenizer for 1 min, then 5 vols buffer A were 
added to the homogenate. The homogenate was 
filtered through a double layer of gauze, layered 
on a 0.8 M sucrose solution in 10 mM imidazole 
(pH 7.5) at 4”C, 1 mM EDTA and 1 mM MgCL 
(15 ml homogenate to 20 ml of 0.8 M sucrose solu- 
tion) and then ultracentrifuged at 113000 x g for 
90 min in an SW-27 bucket rotor. The light sar- 
colemma fraction, floating between 0.25 and 
0.8 M sucrose solutions was collected, 2-fold 
diluted with buffer A, devoid of sucrose and cen- 
trifuged at 120000 x g for 60 min. Membranes 
were suspended in a solution containing 10 mM 
imidazole (pH 7.5) at 4”C, 1 mM EGTA and 
100 mM NaCl (to a final membrane protein con- 
centration of 1 mg/ml), and then preincubated 
with constant shaking for 30 min at 4°C. After 
preincubation, the membrane suspension was cen- 
trifuged at 120000 x g for 60 min. The membrane 
pellet was suspended in 10 mM imidazole (pH 7.5) 
at 4°C (to a final membrane protein concentration 
of 8-10 mg/ml), and was stored in liquid nitrogen. 
CM was isolated from bovine brain as in [12]. 
Troponin I, isolated from bovine heart, was 
generously provided by Dr N.B. Gusev (Depart- 
ment of Biochemistry, Moscow State University). 
Creatine kinase was derived from rabbit skeletal 
muscle as in [ 131 and additionally purified by 
chromatography on DEAE-cellulose. 
The AC activity was measured in an incubation 
medium (final volume 50 $1) containing 50 mM 
Tris-HCl (pH 7.5) at 37”C, 1 mM CAMP, 5 mM 
MgCL, 0.5 mg/ml creatine kinase, 20 mM creatine 
phosphate, 0.1 mM ATP and (0.5-2.0) x lo6 cpm 
[(u-~‘P]ATP. Tubes were equilibrated at the assay 
temperature (37’C) for 1 min prior to starting the 
reaction by addition of membrane preparation to 
a final protein concentration of 0.04-0.06 mg/ml 
(2-3 fig per assay tube). Reaction was carried out 
for 20 min. During assays the basal activity of AC 
was linear with time and protein concentrations, 
and ATP levels were maintained at 98% of the 
original (determined by PEI-cellulose chromato- 
graphy). The reaction was terminated by adding 
200~1 of 0.5 N HCI per tube. The samples were 
boiled in water for 5 min and then neutralized 
with 1.5 M imidazole (200 pi/tube). The labelled 
CAMP formed was purified on an alumina column 
as in [ 141. When kinetic experiments were perform- 
ed the final volume of the incubation mixture was 
1.0-l .5 ml. At zero time the formation of CAMP 
was initiated by the addition of membrane 
preparation (40-90 pug protein). At distinct times 
the reaction was stopped by transferring 50-~1 ali- 
quots in duplicate into 200~1 of 0.5 N HCI. Each 
experiment was performed at least 3 times for each 
batch of membranes. Results quoted are the means 
of triplicate determinations. A standard deviation 
was generally less than 5%. 
Different free calcium concentrations in the in- 
cubation medium were performed by 2 mM 
Ca-EGTA buffer, using for calculation the values 
of stability constants for the Ca2+-EGTA, 
Mg’+--EGTA, and H+-EGTA complexes given in 
1151. 
Protein was determined as in [la]. [~u-~~P]ATP 
was obtained from Amersham; ATP, GTP, 
Gpp(NH)p from Boehringer. Tris, imidazole, 
EDTA, EGTA, CAMP, sucrose, isoproterenol, 
trifluoroperazine and bovine serum albumin were 
purchased from Sigma; creatine phosphate from 
Calbiochem. 
3. RESULTS AND DISCUSSION 
One of the stages in the isolation of light sar- 
colemma from rabbit heart included its preincuba- 
tion with EGTA (see section 2). It was established 
that the treatment of plasma membranes from a 
wide variety of tissues with EGTA or EDTA leads 
to effective removal of the endogenous CM, and 
selectively eliminates the activating effect of 
micromolar calcium concentrations on the mem- 
brane preparation of AC without eliminating the 
inhibitory action of Ca2+ on these enzymes 
preparations [4,17-201. In the EGTA-treated heart 
plasma membrane preparation Ca2+ fails to exhibit 
any activating effect on AC. Moreover, an increase 
of the free Ca2+ concentration from lo-’ to 
lo-’ M induced only a progressive inhibition of 
AC (fig.1). On the other hand, addition of a 
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Fig.1. Effect of CM on the Ca” concentration- 
dependent activity of heart AC. ( D---cI) Activity in the 
absence of CM, (M) activity in the presence of 
1O-5 M CM. 
homogeneous CM from the brain to the incubation 
medium effected an alteration in the heart AC ac- 
tivity’s dependence upon the Ca” concentration. 
Within the concentration range 4 x 10-7-10-” M, 
Ca2+ activated the enzyme. Ca” concentrations 
exceeding low6 M exerted an inhibitory effect on 
AC. It should be noted that the Ca2+-dependent ef- 
fect of CM on heart AC was retained within the 
range of Ca2+ concentrations inhibiting the en- 
zyme (f&.1). If light sarcolemma was isolated from 
the heart under conditions which do not cause ex- 
traction of the endogenous CM, i.e., in the absence 
of EDTA and without EGTA extraction, biphasic 
dependence of the heart AC activity upon the Ca2+ 
concentration was afso manifested in the absence 
of exogenous CM (in ~repara~on). 
The activating effect of CM on cardiac AC was 
inhibited by troponin I and trifluoperazine (fig.2). 
Neither troponin I (10-s M) nor trifluoperazine 
(low5 M) taken in these concentrations affected the 
AC activity in the absence of CM. 
The Ca”-dependent AC activation by CM oc- 
curred both in the absence and in the presence of 
known enzyme activators: Gpp(NH)p, GTP and 
isoproterenol (table 1). The magnitude of CM- 
dependent heart AC activity increased propor- 
tionally to the stimuIat~ve action of these effeetors 
El- wtthout addltmns 
Ev 
trormntn f,to% 
-tr*fiucperazine,tO! 
Fig.2 Elimination of the CM-induced heart AC 
activation by troponin I (10m5 M) and trifluoperazine 
(lo-’ M). Concentrations of free Ca*+ and CM in the 
incubation medium were 10s6 M. 
on the CM-independent enzyme activity, which 
points to the participation of N-protein in the heart 
AC activation by CM. 
Gpp(NH)~ activated heart AC with a marked 
lag phase (fig.?), It is considered that this lag phase 
reflects the process of the N-protein transition to 
an activated state, whereas the interaction of the 
Table 1 
Effect of GTP -c- isoproterenol and Gpp(NH)p on heart 
AC activity in the absence and presence of CM 
Additions 
None 
GTP (1O-4 M) + 
isoproterenol 
(5 x lo-5 M) 
GPPW-QP 
(1O-4 M) 
pm01 cAMP/mg protein per min 
Without lo-* CM CM- 
CM dependent 
activity 
265 i 1 431 Ic_ 9 166 + 9 
375 -t 1 585 z?r 14 210 -t- 14 
545 + 9 953 k 8 408 k 9 
The increments in the activities elicited by addition of 
IO-’ M CM were termed CM-dependent activity. The 
concentration of free Ca”’ in the incubation medium 
was lo-$ M 
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tote OF INCUBATION. min 
Fig.3. Time course of activation of heart AC by IO-’ M 
Gpp(NH)p (@--o), 1O-5 M Gpp(NH)p + 5 x lO-5 M 
isoproterenol (a--O), IO-’ M Gpp(NH)p + IO-’ M 
CM (e----o), 1O-5 M Gpp(NH)p + 5 x IO-’ M 
isoprotereno~ -t IO-’ M CM (+--a). The apparent lag 
period is obtained by extrapoiation (---). 
Concentration of frek Ca2+ in the incubation medium 
was lO-6 M. 
Gpp(NH)p-activated N-protein with a catalytic 
component occurs rapidly, without a lag phase 
[21]. In the presence of isoproterenol, the lag phase 
in the action of Gpp(NH)p disappeared but the 
steady-state activity of AC remained unchanged 
(fig.3). Thus isoproterenol accelerated the activa- 
tion of N-protein without affecting the number of 
functionaliy active catalytic component-N-protein 
complexes formed in the presence of Gpp(NH)p. 
Unlike the hormone, CM did not affect the lag 
phase in Gpp(NH)p action, i.e., it failed to alter 
the velocity of the N-protein transition to the 
Gpp~NH)p-a~ivated state of AC (fig.3). While 
discussing the mechanism by which CM affects 
AC, one cannot avoid mentioning the following 
principal fact: the magnitude of CM-dependent 
AC activity increased propo~ion~ly to the 
deveIopment of the Gpp(NH)p effect (i.e., as the 
N-protein-catalytic component complex is being 
formed), the degree of enzyme activation by CM 
being unchanged with an increase in the concentra- 
tion of this complex. CM equally intensifies the ac- 
tivity of AC activated both by Gpp(NH)p and 
Gpp(NH)p + isoproterenol (fig.3). Since the 
magnitude of CM-dependent AC activity is pro- 
portional to the amount of the N-protein-catalytic 
component complex, one may assume that CM in- 
teracts with the N-protein-cat~~jc component 
complex ‘holo AC’ and increases its catalytic 
turnover. 
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